Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $18.52 USD
Change Today -0.06 / -0.32%
Volume 77.0K
As of 12:36 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

bruker corp (BRKR) Snapshot

Open
$18.62
Previous Close
$18.58
Day High
$18.71
Day Low
$18.32
52 Week High
05/20/15 - $22.32
52 Week Low
11/7/14 - $17.26
Market Cap
3.1B
Average Volume 10 Days
603.3K
EPS TTM
$0.61
Shares Outstanding
168.2M
EX-Date
--
P/E TM
30.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for BRUKER CORP (BRKR)

bruker corp (BRKR) Related Bloomberg News

View More Bloomberg News

bruker corp (BRKR) Related Businessweek News

No Related Businessweek News Found

bruker corp (BRKR) Details

Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. The company offers life science and materials research systems and associated products used in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology, and in-vitro diagnostics. Its technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, infrared and Raman molecular spectroscopy technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, fluorescence optical microscopy, and stylus and optical metrology technology. The company also sells a range of field analytical systems for chemical, biological, radiological, nuclear, and explosive detection; and develops and manufactures low temperature and high temperature superconducting wire products, as well as superconducting wire and superconducting devices for use in magnet technology, physics research, and energy applications. Bruker Corporation’s customer base includes life science, pharmaceutical, biotechnology and molecular diagnostic research companies, academic institutions, advanced materials, and semiconductor industries, as well as government agencies. The company markets its products through direct sales force; and distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

6,100 Employees
Last Reported Date: 02/27/15
Founded in 1991

bruker corp (BRKR) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $598.7K
Interim Chief Financial Officer and Senior Vi...
Total Annual Compensation: $256.5K
President of Bruker Daltonics Division and Pr...
Total Annual Compensation: $717.2K
President of Bruker MAT Group
Total Annual Compensation: $399.5K
Compensation as of Fiscal Year 2014.

bruker corp (BRKR) Key Developments

Bruker Corporation Announces the Appointment of Mr. John Ornell to its Board of Directors and as a Member of the Board’s Audit Committee

Bruker Corporation announced the appointment of Mr. John Ornell to its Board of Directors, effective August 19, 2015. Mr. Ornell will serve for an initial term expiring at the Company’s 2016 Annual Meeting of Stockholders. Mr. Ornell was also appointed to serve as a member of the Board’s Audit Committee. Mr. Ornell recently retired from Waters Corporation, where he served as Chief Financial Officer from 2001 to 2013. During this time at Waters, he was also responsible for information technology, investor relations and the TA Instruments Division.

Bruker Introduces Opterra II Multipoint Scanning Confocal Microscope

Bruker announced the release of the Opterra II™ Multipoint Scanning Confocal Microscope, which represents the next generation of quantitative live-cell microscopes. The Opterra II’s low photo-toxicity and photo-bleaching capabilities deliver significant advantages over spinning disk confocal approaches, including enabling time-lapsed volumetric studies on previously inaccessible specimens. This performance is achieved through the system’s unique ability to optimize an experiment’s imaging conditions through real-time adjustment of imaging speed, resolution, and sensitivity. Additionally, the Opterra II provides sub-10% field uniformity deviation, allowing quantitative analysis, in all dimensions, as a standard feature. Opterra II is based on Bruker’s patented multipoint confocal microscopy technology and swept-field scanner. The new system provides next-generation functionality compared to spinning disk systems through its ability to tailor speed, resolution, and intensity to provide low photo-toxicity and photo-bleaching on any biological specimen. The Opterra II also features a sub-10% field illumination uniformity; options for bypass capability for wide-field, bright-field, and TIRF imaging; a high-speed 10-position filter wheel; as well as photo-activation, spectral imaging and un-mixing capabilities.

Bruker Corporation Approves Appointment of Hermann Requardt to Board of Directors

On August 6, 2015, Bruker Corporation's Board of Directors approved an increase in the number of directors to expand the size of the Board by one director to a total of twelve directors, with such additional director assigned to Class II, and elected Dr. Hermann Requardt to fill the newly-created vacancy on the Board, effective immediately. Dr. Requardt will serve for a term expiring at the company’s 2017 annual meeting of stockholders. Dr. Requardt currently serves as an independent strategic advisor to a number of European public and private life science and healthcare technology companies. From 2009 to February 2015 he served as Chief Executive Officer of the healthcare division of Munich, Siemens AG. He also served as Chief Technology Officer of Siemens AG from 2008 through 2011. Additionally, from 2006 through January 2015 he was a member of the Siemens AG Managing Board, during which time he also held a variety of regional and operational responsibilities at Siemens and its affiliates.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRKR:US $18.52 USD -0.06

BRKR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMerieux €101.00 EUR -1.05
FEI Co $76.27 USD +0.55
National Instruments Corp $29.21 USD -0.05
Teledyne Technologies Inc $98.13 USD -0.48
Teradyne Inc $18.23 USD +0.21
View Industry Companies
 

Industry Analysis

BRKR

Industry Average

Valuation BRKR Industry Range
Price/Earnings 52.5x
Price/Sales 1.9x
Price/Book 4.1x
Price/Cash Flow 52.1x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRUKER CORP, please visit www.bruker.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.